Pharma Inc., collectively "Boston Biomedical", announced that it has appointed Patricia S. Andrews as Executive Vice President and Chief Commercial Officer as it begins strategic planning and preparations for the commercialization of its cancer stem cell inhibitors with its lead asset, BBI608, currently in a global Phase 3 clinical trial for ... (more)
http://www.freshnews.com/news/871584/boston-biomedical-appoints-patricia-s-andrews-chief-commercial-officer
http://www.freshnews.com/news/871584/boston-biomedical-appoints-patricia-s-andrews-chief-commercial-officer
No comments:
Post a Comment